Answers are grounded in this paper and cite their sources.
While guidelines recommend testing and treatment for patients with venom-induced anaphylaxis to prevent morbidity and mortality, significant barriers prevent most patients from receiving the evaluation and treatments that they need. This review examines these barriers in the United States along with the facilitators that can be used to overcome them.
No takes yet. Share an insight, caveat, or question.
Carlson et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: